MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
about
CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function.Regulation of IL-17A production is distinct from IL-17F in a primary human cell co-culture model of T cell-mediated B cell activationCCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells.Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokinesElevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children.Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility loci.Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis.The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.Maternal Diet, Metabolic State, and Inflammatory Response Exert Unique and Long-Lasting Influences on Offspring Behavior in Non-Human Primates.Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
P2860
Q34417523-9D0524F0-B7A8-4056-8114-E9B17C392310Q34626086-741D90F8-90FD-40BF-9C8F-F174F51BD2B0Q35113362-9D64539B-18A2-472F-A674-FFD814382B8EQ35603078-0C6E3CD1-77D3-41CE-AEB6-7CA5EF42B0C7Q35844943-429E33BE-A341-4771-BC5B-E7AEBA1FF3DFQ36372950-9C067501-8B77-41DB-A03F-3248B7FDE83DQ36992632-FBBF370D-672D-4CFB-B187-112DBD02BBCEQ38437890-433FEF4F-54FE-441F-950B-69079AEC19EAQ41732226-83C3DE31-EB45-4C1E-B812-AF373AFDCEF7Q47114458-736BD62E-FA5C-408E-A891-1CFC8D10C680Q55024417-118A1CD1-85A8-4E05-BE46-89B1258E4247Q58796706-135616BE-E8DE-4259-8655-99E43F542D76
P2860
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
@ast
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
@en
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
@nl
type
label
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
@ast
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
@en
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
@nl
prefLabel
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
@ast
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
@en
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
@nl
P2093
P2860
P50
P356
P1476
MDC/CCL22 intrathecal levels in patients with multiple sclerosis
@en
P2093
P2860
P304
P356
10.1177/1352458507084268
P577
2008-01-21T00:00:00Z